The two biggest play­ers in the obe­si­ty mar­ket are head­ed to court.

No­vo Nordisk sued Eli Lil­ly on Tues­day over what it claims are “ma­li­cious­ly...

The FDA is plan­ning to an­nounce a slate of se­nior per­son­nel an­nounce­ments when a new com­mis­sion­er is named, in­clud­ing per­ma­nent heads of CBER and CDER...

In­di­an gener­ic drug­mak­er Alem­bic Phar­ma­ceu­ti­cals has been hit with an FDA warn­ing let­ter af­ter fail­ing to get in­formed con­sent from pa­tients for a clin­i­cal study...

No­var­tis is­n't mak­ing deals in Chi­na just for the sake of buy­ing there.

That's the word from CEO Vas Narasimhan, who told re­porters on a...

Gilead and Mer­ck’s HIV da­ta: The duo will presentmore de­tailed re­sults of the Phase 3 tri­als of their once-week­ly oral HIV treat­ment reg­i­men at...

Agios said it is drop­ping a next-gen­er­a­tion sick­le cell dis­ease drug af­ter lack­lus­ter re­sults from a mid-stage tri­al.

The drug, known as tebapi­vat, rep­re­sent­ed Agios’ sec­ond...